TriSalus Life Sciences, Inc. TLSI Derivative Liabilities (Non-Current)
Derivative Liabilities (Non-Current) at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DerivativeLiabilitiesNoncurrent.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s derivative liabilities (non-current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s derivative liabilities (non-current)?
- TriSalus Life Sciences, Inc. (TLSI) reported derivative liabilities (non-current) of $9.08M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s derivative liabilities (non-current) changed year-over-year?
- TriSalus Life Sciences, Inc.'s derivative liabilities (non-current) decreased by 4.1% year-over-year, from $9.46M to $9.08M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s derivative liabilities (non-current)?
- Over 3 years (2022 to 2025), TriSalus Life Sciences, Inc.'s derivative liabilities (non-current) has grown at a 226.9% compound annual growth rate (CAGR), from $369K to $12.89M.
- What does derivative liabilities (non-current) mean?
- This represents the fair value of derivative financial instruments that are in a liability position and are expected to be settled beyond the next twelve months. These instruments are often used for hedging risks or as part of complex financing arrangements. Tracking this metric helps investors understand the company's exposure to market volatility and long-term financial risk management.